10-63168063-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032776.3(JMJD1C):​c.7605G>C​(p.Glu2535Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.463 in 1,584,334 control chromosomes in the GnomAD database, including 173,701 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14532 hom., cov: 32)
Exomes 𝑓: 0.47 ( 159169 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

1
1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.00500

Publications

79 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.9492378E-4).
BP6
Variant 10-63168063-C-G is Benign according to our data. Variant chr10-63168063-C-G is described in ClinVar as Benign. ClinVar VariationId is 1167960.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.515 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.7605G>C p.Glu2535Asp missense_variant Exon 26 of 26 ENST00000399262.7 NP_116165.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.7605G>C p.Glu2535Asp missense_variant Exon 26 of 26 5 NM_032776.3 ENSP00000382204.2
JMJD1CENST00000542921.5 linkc.7059G>C p.Glu2353Asp missense_variant Exon 25 of 25 1 ENSP00000444682.1
JMJD1CENST00000402544.5 linkn.7296G>C non_coding_transcript_exon_variant Exon 22 of 22 1
JMJD1CENST00000467356.5 linkn.463G>C non_coding_transcript_exon_variant Exon 3 of 3 1

Frequencies

GnomAD3 genomes
AF:
0.428
AC:
64991
AN:
151814
Hom.:
14546
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.327
Gnomad AMI
AF:
0.634
Gnomad AMR
AF:
0.345
Gnomad ASJ
AF:
0.588
Gnomad EAS
AF:
0.356
Gnomad SAS
AF:
0.534
Gnomad FIN
AF:
0.476
Gnomad MID
AF:
0.433
Gnomad NFE
AF:
0.488
Gnomad OTH
AF:
0.427
GnomAD2 exomes
AF:
0.438
AC:
108928
AN:
248440
AF XY:
0.452
show subpopulations
Gnomad AFR exome
AF:
0.328
Gnomad AMR exome
AF:
0.248
Gnomad ASJ exome
AF:
0.571
Gnomad EAS exome
AF:
0.334
Gnomad FIN exome
AF:
0.470
Gnomad NFE exome
AF:
0.484
Gnomad OTH exome
AF:
0.454
GnomAD4 exome
AF:
0.467
AC:
668979
AN:
1432402
Hom.:
159169
Cov.:
27
AF XY:
0.472
AC XY:
337084
AN XY:
714480
show subpopulations
African (AFR)
AF:
0.322
AC:
10588
AN:
32908
American (AMR)
AF:
0.260
AC:
11604
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
0.572
AC:
14814
AN:
25906
East Asian (EAS)
AF:
0.418
AC:
16500
AN:
39500
South Asian (SAS)
AF:
0.533
AC:
45572
AN:
85508
European-Finnish (FIN)
AF:
0.478
AC:
25201
AN:
52718
Middle Eastern (MID)
AF:
0.438
AC:
2508
AN:
5720
European-Non Finnish (NFE)
AF:
0.474
AC:
515127
AN:
1086142
Other (OTH)
AF:
0.456
AC:
27065
AN:
59410
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
14846
29692
44538
59384
74230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14902
29804
44706
59608
74510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.428
AC:
64963
AN:
151932
Hom.:
14532
Cov.:
32
AF XY:
0.428
AC XY:
31758
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.326
AC:
13525
AN:
41450
American (AMR)
AF:
0.344
AC:
5253
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.588
AC:
2038
AN:
3468
East Asian (EAS)
AF:
0.354
AC:
1829
AN:
5160
South Asian (SAS)
AF:
0.532
AC:
2566
AN:
4824
European-Finnish (FIN)
AF:
0.476
AC:
5017
AN:
10548
Middle Eastern (MID)
AF:
0.425
AC:
124
AN:
292
European-Non Finnish (NFE)
AF:
0.488
AC:
33140
AN:
67914
Other (OTH)
AF:
0.425
AC:
894
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1858
3716
5575
7433
9291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.479
Hom.:
13748
Bravo
AF:
0.405
TwinsUK
AF:
0.486
AC:
1803
ALSPAC
AF:
0.475
AC:
1831
ESP6500AA
AF:
0.340
AC:
1271
ESP6500EA
AF:
0.478
AC:
3919
ExAC
AF:
0.445
AC:
53808
Asia WGS
AF:
0.418
AC:
1452
AN:
3476
EpiCase
AF:
0.488
EpiControl
AF:
0.480

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Early myoclonic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
10
DANN
Uncertain
1.0
DEOGEN2
Benign
0.011
.;T;.
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.66
T;T;T
MetaRNN
Benign
0.00029
T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.1
.;L;.
PhyloP100
0.0050
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.38
.;N;N
REVEL
Benign
0.090
Sift
Benign
0.17
.;T;T
Sift4G
Pathogenic
0.0
.;D;D
Polyphen
0.35
.;B;.
Vest4
0.060, 0.16
MutPred
0.095
.;Loss of loop (P = 0.1258);.;
MPC
0.99
ClinPred
0.013
T
GERP RS
3.6
Varity_R
0.054
gMVP
0.16
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1935; hg19: chr10-64927823; COSMIC: COSV67858085; API